Laboratory “Sensor-Tech” has been established to solve most ambitious scientific goals and create advanced technologies for people with hearing and visual impairments, including the deaf-blind, in Russia and in the world. In our work, we apply modern technologies, including AI, and develop products that empower people with sensory impairments. Nowadays, our key projects are: Smart assistant “Robin”, designed to enable blind people to better orientate themselves indoors and outdoors. “Robin” can recognize objects, people and their faces, determine distance to them and detect obstacles with the help of an ultrasonic radar. “Robin” works without Internet connection or third-party applications. Developed as a complement to a white cane, “Robin” is simple to use and does not require long training. Our other flagship product – Speech recognition device “Charly”, designed for independent communication with hearing impaired people. “Charly” recognizes speech, converts it into text and displays recognized speech on a monitor, a mobile phone, a TV, or a Braille display. “Charly” also allows to work and study remotely. Besides, we have launched Ophthalmic VR-simulator “See My World”, mobile apps “Currency note recognizer” and “Object recognizer”, implement a large genetic research in Russia and organized the first retinal implant surgeries (bionic vision) in Russia.

4Blind company conducts research, develop, create and produce innovative technologies for the rehabilitation and improvement the quality of life of blind and deaf-blind people. 4Blind technical solutions: help them to communicate; give access to information around them; help develop in the professional field.

Advantages of 4Blind solutions: multifunctionality, its suitability for various objectives such as reading, writing, communication, the use of mobile phone, tactile access to graphic information; lack of comparable analogues in the market or absence of analogues; ease of use and servicing; affordable price.

Market opportunities: according to the latest report of the WHO in the world more than 7 million deafblind and more than 285 million blind people.

Sales strategy: direct sales to support organizations and foundations for people who are blind and deaf-blind, rehabilitation centers for the deaf-blind people, public and private companies providing jobs for people with disabilities, insurance companies; sales through international distributors of technical rehabilitation equipment, as well as sale of licenses for the right to manufacture the device in other countries.

We’ve already conducted testing of devices in associations and funds engaged in the support of blind and deafblind people having received confirmation that users need them, and devices meet expectations.

The global drone market was valued at USD 18.11 Bn in 2018 with a CAGR of 19.90% and is expected to reach 88.57 Bn by the end of 2027. While hardware companies continue to improve drone technology, drone service providers are creating solutions that provide an excellent return on investment. However the next five years will be about leveraging drone data to integrate, automate, and communicate multiple streams of data. Our team has the know-how to inform about the human and environmental factors in large workplaces. As drone hardware advances, more industries will bring this technology in-house reducing the need for service providers. Our technology bridges this transition by fusing the physical and digital to address present needs for a reformation of the work place.

Our platform as a service provides and integrates 2D maps and 3D digital twins of large spaces, real time tracking and various sensors, to address fast and slow disasters and their surrounding industries including insurance, real estate, construction, and renewable energy. Our software aims to change the way these industries communicate across stakeholders, allocate resources, and think about safety protocols. Our product can be thought of as workplace building blocks for the ‘new normal’.

JN Medsys is a Singapore biomedical company dedicated to providing super resolution genomic tools for precise and personalized diagnostics. Founded in 2010, our vision is to improve lives through advanced diagnostics in healthcare. We have been working relentlessly over the years to create cutting-edge genomic tools, comprising instruments and kits, that provide better sensitivity and accuracy for nucleic acids analysis. Through these advanced diagnostics, we hope to generate actionable insights to improve the outcomes of cancer and to eradicate infectious diseases. More recently, we have developed an end-to-end solution for Covid-19 testing. Our test is able to provide accurate, fast, and high capacity Covid-19 testing, even for countries which have limited resources.

Meracle brings relief and assurance to patients with respiratory and chronic ailments by optimizing the delivery of therapy in a safe, reliable and efficient manner, with the ultimate goal of setting the industry’s benchmarks and standards. Meracle’s first product, the Whizz, improves the management of respiratory conditions by increasing the efficiency of medication delivered into the lungs while tracking intake data to augment the assessment of treatment outcomes. Through trials we have shown that the Whizz improves technique and compliance by 100%, leading to better asthma control and reduced symptoms. The system consist of a hardware that helps deliver medication effectively to patients, paired to a mobile application that has multiple features to track and encourage compliance through gamification as well as manage treatment regimen. The data collected benefits multiple stakeholders, by first improving the quality of life of patients and helping them gain a sense of control over their situation. Doctors have access to objective data that makes it easier to target accurate prescription medication and governments are able to improve public health and reduce the burden on an overwhelmed healthcare system.

nplasty Pte Ltd (“nplasty”) is an X Reality (“AR/VR/MR”) company that leverages immersive VR technology for orthopaedic surgical training through visual simulation. nplasty’s pioneer product is an orthopaedic surgical training solution for the healthcare community that utilises haptic feedback to provide a more realistic and immersive experience. It provides solutions for various use cases – knee and hip procedures currently with further orthopaedic subspecialties (spine, trauma, upper limb, lower limb, etc.) planned for the future.

Opsis is spin-off from A*STAR based on 5 years of R&D in MedTech research. The technology has use-cases in:
• Tele-Health, where video care providers get real time emotional feedback on the state of the people in needs. Discover and interventions with any video platform or devices.
• Tele-Education with insights metrics on teaching content receptiveness and help educators to identify online learners: Confuse, Stress or Bored.
• Tele-HR for online recruitment or training with deepen behavioral analysis data for interpretation based on psychometric evaluation.
Awards and Accolades
• 1st place in the OMG Emotion Behaviour Challenge 2018
• 2nd place in EmotiW2016 competition (ICMI)
• 3rd place in EmotiW2015 competition (ICMI)
• 2nd place in Grand Challenge Competition (ACM Multimedia 2012)
The key differentiating from those in the market are:
• Only 1 in the world using psychology circumplex model resulting in more precise emotion measurements with 2 Dimension data points.
• Real-time processing and analysis for individual and large crowd group emotional state. Most competitors allow for only single analysis.
• Technology accounts for ethnicity differences with high accuracy of 93% vs 70% available in the market.
• Thousands of mood detection with interactive responds vs 7 basis labelling
• Deployment platform includes: APP, SDK, Raspberry Pi, Cloud Service

Roceso Technologies is a world pioneer in soft robotic exoskeleton technologies. Its soft robotic solutions provide functional assistance to patients with limb motor function impairments during rehabilitation and daily living. The company’s flagship product, the EsoGLOVE, is one of the world lightest hand rehabilitation and exoskeleton devices offering top functionality and comfort. Since 2020, Roceso Technologies have expanded to three business units: Rehabilitation and Assistive Technologies, Venous Care and Contracture Management, Compression and Support.